MEHCQ News and Press, 23andMe Holding

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that it has completed the acquisition of the Personal Genome Service (PGS) and Research...

SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a genetics-led consumer healthcare company, today announced that it has received approval from the U.S. Bankruptcy Court for the Eastern District of Missouri...

2025-06-17 09:44:23 ET More on Regeneron Pharmaceuticals, 23andMe Regeneron Pharmaceuticals, Inc. (REGN) Presents at 46th Annual Goldman Sachs Global Healthcare Conference Transcript Itepekimab Failure A Setback For Sanofi And Regeneron Regeneron's 23andMe Steal - Sm...

2025-06-13 17:21:18 ET More on 23andMe 23andMe sued by state attorneys general over plans to sell genetic data 23andMe seeks second auction as ex-CEO outbids Regeneron Seeking Alpha’s Quant Rating on 23andMe Historical earnings data for 23andMe ...

TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data and Privacy No Changes to 23andMe’s Privacy Policy or Consumer G...

2025-06-10 15:55:51 ET More on 23andMe 23andMe seeks second auction as ex-CEO outbids Regeneron Regeneron to buy 23andMe for $256M in court-supervised sale Seeking Alpha’s Quant Rating on 23andMe Historical earnings data for 23andMe Financial i...

2025-06-05 12:21:00 ET Listen below or on the go on Apple Podcasts and Spotify Tesla stock has wobbled as Elon Musk lashes out against the Big Beautiful Bill. (0:15) Trade deficit plunges in April. (1:53) Battle for 23andMe heats up . (3:48) ... Rea...

2025-06-05 07:13:35 ET More on 23andMe, Regeneron Pharmaceuticals Itepekimab Failure A Setback For Sanofi And Regeneron Regeneron's 23andMe Steal - Smart Genetics Play That Won't Cure Near-Term Growth Pains Regeneron Pharmaceuticals, Inc. (REGN) RBC Capital Markets G...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file a Form 25 Notification of Delisting with the Securities and Exchange...

2025-05-19 07:32:26 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. (REGN) BofA Securities 2025 Healthcare Conference (Transcript) Regeneron Continues To Regenerate Its Drug Pipeline, While Keeping Leverage Down Regeneron Pharmaceuticals, Inc. (R...